Yuichi Ando

18PUBLICATIONS

62CO-AUTHORS

Predictive and prognostic markersPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsRadiation therapy

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|Jul 15, 2026

Comprehensive genomic profiling and tumor mutational burden in parathyroid carcinoma: a nationwide real-world study from Japan.

|Jul 02, 2025

Pazopanib and antacids: insights from the WHO pharmacovigilance database.

Kazuki Nishida, Yao Liang, Osamu Maeda

|Jun 14, 2025

Safety and efficacy of retreatment with immune checkpoint inhibitors after severe immune-related adverse events.

Kazuyuki Mizuno, Takanori Ito, Tsunaki Sawada

|Jan 31, 2025

Genomic profiles of patients with skin melanoma in the era of immune checkpoint inhibitors.

Yao Liang, Osamu Maeda, Kazuki Nishida

|Oct 28, 2024

<i>UGT1A1</i> Testing for the Risk of Nanoliposomal Irinotecan-Related Toxicity.

Yao Liang, Yuichi Ando

|Jul 22, 2024

Effects of KRAS, STK11, KEAP1, and TP53 mutations on the clinical outcomes of immune checkpoint inhibitors among patients with lung adenocarcinoma.

Yao Liang, Osamu Maeda, Chiaki Kondo

Pageof 3

Frequent Collaborators

Yao Liang

Osamu Maeda

Hironobu Minami

Kazuki Nishida

Kenji Tamura

Yoshihiro Nishida

Hiroshi Urakawa

Yoshinori Imamura

Yuko Takano

Martin Schuler

Frequent Collaborators

Yao Liang

Osamu Maeda

Hironobu Minami

Kazuki Nishida